Featured Research

from universities, journals, and other organizations

Columbus May Have Brought Syphilis To Europe From New World

Date:
January 15, 2008
Source:
PLoS Neglected Tropical Diseases
Summary:
Did Columbus and his men introduce the syphilis pathogen into Renaissance Europe after contracting it during their voyage to the New World? Or does syphilis have a much longer history in the Old World? The most comprehensive comparative genetic analysis conducted on the family of bacteria that cause syphilis and related diseases supports the so-called "Columbian theory" of syphilis' origins.

A network path for four informative substitutions shows that New World subsp. pertenue, or yaws-causing strains, are the closest relatives of modern subsp. pallidum strains. On the map green represents endemic syphilis; red, yaws; numbers show the number of nucleotide substitutions.
Credit: Harper KN, Ocampo PS, Steiner BM, George RW, Silverman MS, et al.

Did Columbus and his men introduce the syphilis pathogen into Renaissance Europe after contracting it during their voyage to the New World? Or does syphilis have a much longer history in the Old World? The most comprehensive comparative genetic analysis conducted on the family of bacteria (the treponemes) that cause syphilis and related diseases such as yaws supports the so-called "Columbian theory" of syphilis's origins.

Kristin Harper (Emory University, Atlanta, USA) approached this centuries-old debate by using phylogenetics -- the study of the evolutionary relatedness between organisms -- to study 26 geographically disparate strains of treponemes. The venereal syphilis-causing strains originated most recently, and their closest relatives were strains collected in South America that cause the treponemal disease yaws.

"That supports the hypothesis that syphilis -- or some progenitor -- came from the New World," Harper says.

While it is generally agreed that the first recorded epidemic of syphilis occurred in Europe in 1495, controversy has raged ever since over the origin of the pathogen. Most of the evidence in recent years has come from bones of past civilizations in both New World and Old World sites, since chronic syphilis causes skeletal lesions. In many cases, however, skeletal analysis is inconclusive, due to problems with pinpointing the age of the bones and the lack of supporting epidemiological evidence.

Further complicating the research is the fact that the family of Treponema bacteria causes different diseases that share some symptoms but have different modes of transmission. Syphilis is sexually transmitted, but yaws and endemic syphilis are tropical diseases that are transmitted through skin-to-skin or oral contact. One hypothesis is that a subspecies of Treponema from the warm, moist climate of the tropical New World mutated into the venereal, syphilis-causing subspecies to survive in the cooler and relatively more hygienic European environment.

The phylogenetic analysis indicated that yaws is an ancient infection in humans while venereal syphilis arose relatively recently. The study results are especially significant due to the large number of different strains analyzed, including two never-before-sequenced strains of yaws from isolated inhabitants of Guyana's interior. At Harper's request, the Guyana samples were collected during a medical mission by Ve'ahavta, the Canadian Jewish Humanitarian and Relief Committee.

"Syphilis was a major killer in Europe during the Renaissance," says co-author George Armelagos, a skeletal biologist whose research put him at the forefront of the syphilis debate 30 years ago. "Understanding its evolution is important not just for biology, but for understanding social and political history. It could be argued that syphilis is one of the important early examples of globalization and disease, and globalization remains an important factor in emerging diseases."

Citation: Harper KN, Ocampo PS, Steiner BM, George RW, Silverman MS, et al. (2008) On the Origin of the Treponematoses: A Phylogenetic Approach. PLoS Negl Trop Dis 2(1): e148. doi:10.1371/journal.pntd.0000148


Story Source:

The above story is based on materials provided by PLoS Neglected Tropical Diseases. Note: Materials may be edited for content and length.


Cite This Page:

PLoS Neglected Tropical Diseases. "Columbus May Have Brought Syphilis To Europe From New World." ScienceDaily. ScienceDaily, 15 January 2008. <www.sciencedaily.com/releases/2008/01/080114213238.htm>.
PLoS Neglected Tropical Diseases. (2008, January 15). Columbus May Have Brought Syphilis To Europe From New World. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/01/080114213238.htm
PLoS Neglected Tropical Diseases. "Columbus May Have Brought Syphilis To Europe From New World." ScienceDaily. www.sciencedaily.com/releases/2008/01/080114213238.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins